AR and prostate cancer: Reciprocal feedback inhibition of AR by PI3K signaling in prostatic cancer has been reported, with the inhibition of PI3K leading to the derepression and activation of AR target genes, and the inhibition of AR leading to reciprocal PI3K pathway activation 43.